It promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A [96], and is also involved in hepatocellular carcinoma by modulating Notch signaling through its interaction with miR-7-5p [97]. This evidence concerns the gene KLF2 and breast cancer.